Los puntos clave no están disponibles para este artículo en este momento.
Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator-activated receptor delta agonist, has potential benefits.
Hirschfield et al. (Wed,) studied this question.